Rise in Prevalence of Infectious Diseases Expected to Drive Global Antimicrobial Susceptibility Test Market: Ken Research

0


Antibacterial susceptibility testing is used to determine the specific drugs that can affect the particular bacteria. These tests provide supervision to the physician in drug preference & dosage for difficult-to-treat infections. The antimicrobial tests can provide superior treatment facilities to cooperate with the complex situation that affects individuals of all ages and races

According to study, “Global Antimicrobial Susceptibility Test Market to reach USD 4.3 billion by 2026” the key companies operating in the global antimicrobial susceptibility test market are Bio-Rad Laboratories, Inc., Biomerieux, HiMedia Laboratories, Becton Dickinson, and Company, Alifax, Danaher Corporation, Creative Diagnostics, Thermo Fisher Scientific Inc., Resistell AG and Merck KGaA.

Based on product, antimicrobial susceptibility test market is segmented as manual antimicrobial susceptibility testing products, automated laboratory instruments, MIC strips, susceptibility testing disks, culture & growth media, susceptibility plates and consumables. Based on method, market is segmented as disk diffusion, dilution, automated antimicrobial susceptibility testing, ETEST and genotypic methods. The disk diffusion segment dominates the market as its low cost and flexible nature of these methods. Based on testing type, market is segmented as antifungal testing, antibacterial testing, antiparasitic testing and others (viruses and fastidious organism testing among others). The antibacterial testing segment is projected to exhibit substantial growth rate due to rise in prevalence of infections caused by bacterial pathogens and increasing guidelines streamlining the process of antimicrobial susceptibility test during the forecast period. Based on application, market is segmented as drug discovery & development, clinical diagnostics, epidemiology and other applications (Bioterrorism Surveillance, veterinary diagnostics, research & academic applications, and environmental monitoring). Clinical diagnostics segment holds major share in global market because of rise in prevalence of infectious diseases, growth in awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications and increase in burden of antimicrobial resistance. In addition, based on end-user, market is segmented as pharmaceutical & biotechnology companies, research & academic institutes, diagnostic centers & hospitals and Contract Research Organizations (CROs). The diagnostic laboratories and hospitals segment is predicted to witness higher CAGR caused by rise in healthcare expenditure coupled with increase in number of initiatives dedicated towards better antibiotic use during the forecast period.

The antimicrobial susceptibility test market is driven by rise in prevalence of infectious diseases, followed by growth in technological advancements towards the development of rapid antimicrobial susceptibility test methods, increase in funding, research grants, and public-private investments and emergence of multidrug resistance due to drug abuse. However, unfavorable reimbursement scenario may impact the market. Moreover, increase in initiatives to detect & control antimicrobial-resistant species is a key opportunity for market.

Based on geography, the North-American region holds major share in global antimicrobial susceptibility test market owing to rise in incidence of antibiotic-resistant infections, increase in use of antimicrobial testing in the region. Whereas, the European and Asian-Pacific regions are expected to witness higher growth rate due to increasingly becoming saturated and manufacturers & suppliers of antimicrobial susceptibility test products in the countries like India and China over the forecast period. In upcoming years, it is estimated that future of the global market will be bright on account of well-established awareness programs for precision medicine during the forecast period. The global antimicrobial susceptibility test market is valued approximately at US $3.0 billion in 2019 and is likely to grow with a healthy growth rate of more than 5.2% over the forecast period 2020 to 2026.

For More Information, click on the link below:-

Global Antimicrobial Susceptibility Test Market Research Report

Related Reports:-

Global Antimicrobial Susceptibility Testing Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

ankur@kenresearch.com

+91-9015378249

Share.

Comments are closed.